Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline Begins Phase 3 Melanoma Study
GlaxoSmithKline Begins Phase 3 Melanoma Study
GlaxoSmithKline Begins Phase 3 Melanoma Study
Submitted by
admin
on February 4, 2013 - 11:24am
Source:
Motley Fool
News Tags:
GSK
melanoma
BRAF inhibitor
dabrafenid
MEK inhibitor
trametinib
Headline:
GlaxoSmithKline Begins Phase 3 Melanoma Study
Do Not Allow Advertisers to Use My Personal information
